Chennai: City-based Orchid Chemicals and Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) for abbreviated new drug applications (ANDA) for Piperacillin and Tazobactam injections.
The FDA has granted 180-day generic drug exclusivity for marketing the products. Orchid will sell the drugs in the US in partnership with Canada’s Apotex.
